Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NNDM
3276
Nano Dimension
NNDM
$343M
| $1.26M | ﹤0.01% |
450,958
+4,380
| +1% | +$11.3K |
|
|
BFIN
3277
DELISTED
BankFinancial
BFIN
| $1.25M | ﹤0.01% |
119,465
| – | – |
|
|
RDNW
3278
RideNow Group
RDNW
$262M
| $1.25M | ﹤0.01% |
194,037
+44,204
| +30% | +$308K |
|
3279
Zura Bio
ZURA
$566M
| $1.25M | ﹤0.01% |
487,125
+437
| +0.1% | +$1.55K |
|
3280
Coya Therapeutics
COYA
$113M
| $1.25M | ﹤0.01% |
125,996
+33,531
| +36% | +$263K |
|
|
AKTS
3281
DELISTED
Akoustis Technologies Inc
AKTS
| $1.24M | ﹤0.01% |
2,099,504
+618,609
| +42% | +$399K |
|
|
KZR
3282
DELISTED
Kezar Life Sciences
KZR
| $1.24M | ﹤0.01% |
137,369
+1,904
| +1% | +$17.3K |
|
3283
Structure Therapeutics
GPCR
$3.78B
| $1.24M | ﹤0.01% |
28,896
+6,702
| +30% | +$283K |
|
3284
Equinor
EQNR
$92.4B
| $1.24M | ﹤0.01% |
45,714
| – | – |
|
3285
NewAmsterdam Pharma
NAMS
$3.34B
| $1.23M | ﹤0.01% |
52,185
+4,861
| +10% | +$98.7K |
|
|
ADTH
3286
DELISTED
AdTheorent Holding Co
ADTH
| $1.23M | ﹤0.01% |
382,611
+9,626
| +3% | +$26.3K |
|
3287
Bassett Furniture
BSET
$176M
| $1.23M | ﹤0.01% |
83,061
+884
| +1% | +$13.6K |
|
3288
Citizens Community Bancorp
CZWI
$202M
| $1.22M | ﹤0.01% |
100,065
+23,698
| +31% | +$282K |
|
3289
Eldorado Gold
EGO
$9.89B
| $1.22M | ﹤0.01% |
86,046
+80
| +0.1% | +$972 |
|
3290
Quest Resource Holding
QRHC
$31.6M
| $1.21M | ﹤0.01% |
141,564
+3,955
| +3% | +$28.2K |
|
|
EGRX
3291
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.21M | ﹤0.01% |
231,641
+6,346
| +3% | +$34.8K |
|
3292
Hawthorn Bancshares
HWBK
$278M
| $1.21M | ﹤0.01% |
59,222
+844
| +1% | +$19.2K |
|
3293
ATS Corp
ATS
$2.05B
| $1.21M | ﹤0.01% |
35,637
+1,228
| +4% | +$48.7K |
|
3294
Friedman Industries
FRD
$317M
| $1.2M | ﹤0.01% |
64,123
-882
| -1% | -$15.1K |
|
3295
Ambev
ABEV
$46.4B
| $1.2M | ﹤0.01% |
484,650
-4,565
| -0.9% | -$11.9K |
|
|
CARM
3296
DELISTED
Carisma Therapeutics
CARM
| $1.2M | ﹤0.01% |
528,589
+12,696
| +2% | +$30.5K |
|
3297
NLI Holdings
NL
$317M
| $1.2M | ﹤0.01% |
163,401
+85
| +0.1% | +$478 |
|
3298
Epsilon Energy
EPSN
$173M
| $1.19M | ﹤0.01% |
217,282
+7,127
| +3% | +$35.5K |
|
|
BLDP
3299
Ballard Power Systems
BLDP
$790M
| $1.19M | ﹤0.01% |
428,899
+11,470
| +3% | +$36.1K |
|
3300
Relmada Therapeutics
RLMD
$527M
| $1.19M | ﹤0.01% |
256,087
+12,674
| +5% | +$61.1K |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.